Biocon share price has plunged 3% and is presently trading at Rs 326.6.
Meanwhile, the BSE HEALTHCARE index is at 40,804.0 (down 0.6%).
Among the top losers in the BSE HEALTHCARE index today are Divis Laboratories (down 2.8%) and Natco Pharma (down 2.7%).
AJANTA PHARMA (up 3.8%) and APOLLO HOSPITALS (up 1.0%) are among the top gainers today.
Over the last one year, Biocon has moved up from Rs 254.6 to Rs 326.6, registering a gain of Rs 72.1 (up 28.3%).
On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 40,804.0, registering a gain of 46.7% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 128.1%), GSK Pharma (up 99.9%) and SUVEN PHARMACEUTICALS (up 95.9%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 78,919.4 .
The top losers among the BSE Sensex today are Ultratech Cement (down 2.2%) and MUNDRA PORT & SEZ (down 1.7%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.
In the meantime, NSE Nifty is at 24,119.2 (down 0.1%). Hero Motocorp and Divis Laboratories are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 78,919.4, registering a gain of 13,517.5 points (up 20.7%).
Biocon net profit grew 373.3% YoY to Rs 8,618 million for the quarter ended June 2024, compared to a profit of Rs 1,821 million a year ago. Net sales rose 0.3% to Rs 34,329 million during the period as against Rs 34,226 million in April-June 2023.
For the year ended March 2024, Biocon reported 101.8% increase in net profit to Rs 12,978 million compared to net profit of Rs 6,430 million during FY23. Revenue of the company grew 32.1% to Rs 147,557 million during FY24.
The current Price to earnings ratio of Biocon, based on rolling 12 month earnings, stands at 19.0.
Equitymaster requests your view! Post a comment on "Biocon Plunges 3%; BSE HEALTHCARE Index Down 0.6%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!